Sundrug Co Ltd (9989) Stock Price & News

9989:TYO

Sundrug Co Ltd

¥3,566.00

-0.06%

(-2.00) 1D

Oct 5, 3:24:40 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 9989...

Open

¥3,560

High

¥3,568

Low

¥3,530

Mkt. cap

425.53B

Avg. vol.

558.09K

Volume

379.60K

Dividend

3.67%

Quarterly dividend

¥33

Ex-dividend date

Sep 29, 2026

P/E ratio

13.26

52-wk high

¥4,466

52-wk low

¥3,515

EPS

¥269

Shares outstanding

116.88M

No. of employees

Open

¥3,560

High

¥3,568

Low

¥3,530

Mkt. cap

425.53B

Avg. vol.

558.09K

Volume

379.60K

Dividend

3.67%

Quarterly dividend

¥33

Ex-dividend date

Sep 29, 2026

P/E ratio

13.26

52-wk high

¥4,466

52-wk low

¥3,515

EPS

¥269

Shares outstanding

116.88M

No. of employees

Related stocks

MatsukiyoCocokara & Co

¥2,436.50

+0.23%

News stories

From web sources and news partners

FXLeaders

25 minutes ago

Dow Futures Lifted as Infrastructure & Data Center CapEx Spark Industrial Rally

www.marketscreener.com

52 minutes ago

Panmure Liberum sets 2027 year-end S&P 500 target at 5,000

TradingView

49 minutes ago

IXIC: Nasdaq Futures Flash Green as Traders Double Down on Risk. Rate-Hike Fear Is Fading

MSN

21 hours ago

This rare market signal has appeared only 2 times in a century. Here is what history says comes next.

About Sundrug Co Ltd

CEO-

Employees7.46K

Founded1957

Headquarters-

SectorDrug

Websitesundrug.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	210.74B	217.27B	206.80B	215.33B
Cost of goods sold	157.16B	161.24B	153.58B	159.96B
Cost of revenue	157.16B	161.24B	153.58B	159.96B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	42.80B	42.55B	24.17B	43.28B
Operating expense	42.80B	42.55B	42.93B	43.28B
Total operating expenses	199.96B	203.79B	196.51B	203.24B
Operating income	10.78B	13.48B	10.30B	12.09B
Other non operating income	188.00M	224.00M	197.00M	191.00M
EBT including unusual items	10.62B	13.25B	9.84B	11.91B
EBT excluding unusual items	10.75B	13.30B	10.02B	11.88B
Income tax expense	3.29B	4.29B	2.68B	3.89B
Effective tax rate	31.01%	32.37%	27.26%	32.68%
Other operating expenses	-	-	-	-
Net income	7.32B	8.96B	7.16B	8.02B
Net profit margin	3.48%	4.12%	3.46%	3.72%
Earnings per share	-	-	-	-
Interest and investment income	86.00M	30.00M	98.00M	28.00M
Interest expense	-88.00M	-91.00M	-125.00M	-136.00M
Net interest expenses	-2.00M	-61.00M	-27.00M	-108.00M
Depreciation and amortization charges	-	-	18.76B	-
EBITDA	15.23B	17.80B	14.98B	16.78B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything